Keywords: Clinical trial reporting, Transparency, EMA, Industry and media relations, PLoS

Greater transparency needed in publishing information from clinical trials

Article | 30 January 2013

An initiative from the drugs regulator the European Medicines Agency to commit to releasing all of the information from clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in